Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 10, Issue 1, Pages 129-137
Publisher
Informa Healthcare
Online
2013-12-03
DOI
10.1517/17425255.2014.865723
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic considerations of drugs in the treatment of allergic diseases
- (2013) Elena García-Martín et al. Expert Opinion on Drug Metabolism & Toxicology
- Indacaterol
- (2012) Kate McKeage DRUGS
- Systemic pharmacokinetics of indacaterol, an inhaled once-daily long-acting ?2-agonist, in different ethnic populations
- (2012) Soichiro Matsushima et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Validation of an on-line solid-phase extraction method coupled to liquid chromatography–tandem mass spectrometry detection for the determination of Indacaterol in human serum
- (2012) Corinne Emotte et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol
- (2012) Mario Cazzola et al. RESPIRATORY MEDICINE
- Safety, tolerability and pharmacokinetics of single escalating doses of indacaterol, a once-daily beta2-agonist bronchodilator, in subjects with COPD
- (2011) S. Pascoe et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study
- (2011) Sanjeev Khindri et al. BMC Pulmonary Medicine
- Safety of indacaterol in the treatment of patients with COPD
- (2011) James Donohue et al. International Journal of Chronic Obstructive Pulmonary Disease
- Efficacy, Safety and Pharmacokinetics of Indacaterol in Caucasian and Japanese Patients with Chronic Obstructive Pulmonary Disease
- (2010) Motoi Hosoe et al. CLINICAL DRUG INVESTIGATION
- The Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist
- (2010) François Baur et al. JOURNAL OF MEDICINAL CHEMISTRY
- Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design
- (2010) Peter J. Barnes et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Indacaterol once-daily is equally effective dosed in the evening or morning in COPD
- (2010) H. Magnussen et al. RESPIRATORY MEDICINE
- Lipid membrane interactions of indacaterol and salmeterol: Do they influence their pharmacological properties?
- (2009) Dario Lombardi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison
- (2008) Stephen Rennard et al. RESPIRATORY MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started